MECHANISMS OF DISEASE Alzheimer's Disease

被引:3499
作者
Querfurth, Henry W. [1 ,2 ,3 ,4 ]
LaFerla, Frank M. [5 ]
机构
[1] Rhode Isl Hosp, Dept Neurol, Providence, RI 02903 USA
[2] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA
[3] Tufts Med Ctr, Dept Neurol, Boston, MA USA
[4] Caritas St Elizabeths Med Ctr, Dept Neurol, Brighton, MA USA
[5] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA
关键词
AMYLOID-BETA-PROTEIN; NICOTINIC ACETYLCHOLINE-RECEPTOR; INSULIN-DEGRADING ENZYME; BLOOD-BRAIN-BARRIER; GENOME-WIDE ASSOCIATION; LONG-TERM POTENTIATION; NEURONAL CELL-DEATH; A-BETA; MOUSE MODEL; PRECURSOR PROTEIN;
D O I
10.1056/NEJMra0909142
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:329 / 344
页数:16
相关论文
共 195 条
[71]   The atorvastatin/donepezil in Alzheimer's disease study (LEADe): Design and baseline characteristics [J].
Jones, Roy W. ;
Kivipelto, Miia ;
Feldman, Howard ;
Sparks, Larry ;
Doody, Rachelle ;
Waters, David D. ;
Hey-Hadavi, Judith ;
Breazna, Andrei ;
Schindler, Rachel J. ;
Ramos, Harry .
ALZHEIMERS & DEMENTIA, 2008, 4 (02) :145-153
[72]   Kinesin-mediated axonal transport of a membrane compartment containing β-secretase and presenilin-1 requires APP [J].
Kamal, A ;
Almenar-Queralt, A ;
LeBlanc, JF ;
Roberts, EA ;
Goldstein, LSB .
NATURE, 2001, 414 (6864) :643-648
[73]   APP processing and synaptic function [J].
Kamenetz, F ;
Tomita, T ;
Hsieh, H ;
Seabrook, G ;
Borchelt, D ;
Iwatsubo, T ;
Sisodia, S ;
Malinow, R .
NEURON, 2003, 37 (06) :925-937
[74]   Human neprilysin is capable of degrading amyloid β peptide not only in the monomeric form but also the pathological oligomeric form [J].
Kanemitsu, H ;
Tomiyama, T ;
Mori, H .
NEUROSCIENCE LETTERS, 2003, 350 (02) :113-116
[75]   Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis [J].
Kayed, R ;
Head, E ;
Thompson, JL ;
McIntire, TM ;
Milton, SC ;
Cotman, CW ;
Glabe, CG .
SCIENCE, 2003, 300 (5618) :486-489
[76]   4-hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes [J].
Keller, JN ;
Mark, RJ ;
Bruce, AJ ;
Blanc, E ;
Rothstein, JD ;
Uchida, K ;
Waeg, G ;
Mattson, MP .
NEUROSCIENCE, 1997, 80 (03) :685-696
[77]   Inducible expression of tau repeat domain in cell models of tauopathy - Aggregation is toxic to cells but can be reversed by inhibitor drugs [J].
Khlistunova, I ;
Biernat, J ;
Wang, YP ;
Pickhardt, M ;
von Bergen, M ;
Gazova, Z ;
Mandelkow, E ;
Mandelkow, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (02) :1205-1214
[78]   Midlife vascular risk factors and Alzheimer's disease in later life:: longitudinal, population based study [J].
Kivipelto, M ;
Helkala, EL ;
Laakso, MP ;
Hänninen, T ;
Hallikainen, M ;
Alhainen, K ;
Soininen, H ;
Tuomilehto, J ;
Nissien, A .
BMJ-BRITISH MEDICAL JOURNAL, 2001, 322 (7300) :1447-1451
[79]   Oxidative stress, cell cycle, and neurodegeneration [J].
Klein, JA ;
Ackerman, SL .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (06) :785-793
[80]   Targeting small Aβ oligomers:: the solution to an Alzheimer's disease conundrum? [J].
Klein, WL ;
Krafft, GA ;
Finch, CE .
TRENDS IN NEUROSCIENCES, 2001, 24 (04) :219-224